A pooled analysis of individual patient data from the major bivalirudin versus unfractionated heparin trials concludes that preprocedural bivalirudin could be considered the agent of choice in the ...
Researchers moved one step closer to the ability to make heparin in cultured cells. Heparin is a potent anti-coagulant and the most prescribed drug in hospitals, yet cell-culture-based production of ...